Grandfield & Dodd, LLC Bristol Myers Squibb CO Transaction History

Grandfield & Dodd, LLC

$1.5 Billion
Q1 2024

A detailed history of Grandfield & Dodd, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 13,234 shares of BMY stock, worth $564,297. This represents 0.05% of its overall portfolio holdings.

Number of Shares

13,234

Previous 14,140 6.41%

Holding current value

$564,297

Previous $725,000 1.1%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $43,469 - $49,286	-906 Reduced 6.41%	13,234 $717,000
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $4,411 - $5,264	91 Added 0.65%	14,140 $725,000
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $8,162 - $9,126	-141 Reduced 0.99%	14,049 $815,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $282,617 - $313,802	-4,436 Reduced 23.82%	14,190 $907,000
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $8,870 - $10,061	-135 Reduced 0.72%	18,626 $1.29 Million

Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $17,188 - $20,353	-251 Reduced 1.32%	18,761 $0
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $117 - $69,386	903 Added 4.99%	19,012 $1.35 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $2,178 - $2,399	-30 Reduced 0.17%	18,109 $1.39 Million
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $46,294 - $55,511	-753 Reduced 3.99%	18,139 $1.32 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $15,874 - $18,505	-296 Reduced 1.54%	18,892 $1.18 Million
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $10,295 - $12,059	174 Added 0.92%	19,188 $1.14 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $17,396 - $18,945	281 Added 1.5%	19,014 $1.27 Million
Q1 2021 Apr 22, 2021	BUY	$59.34 - $66.74 $11,868 - $13,347	200 Added 1.08%	18,733 $1.18 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $6,697 - $7,589	116 Added 0.63%	18,533 $1.15 Million
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $229 - $254	-4 Reduced 0.02%	18,417 $1.11 Million
Q2 2020 Jul 24, 2020	BUY	$54.82 - $64.09 $9,703 - $11,343	177 Added 0.97%	18,421 $1.08 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $22,086 - $32,096	476 Added 2.68%	18,244 $1.02 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $125,190 - $163,299	2,544 Added 16.71%	17,768 $1.14 Million
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $6,415 - $7,606	-150 Reduced 0.98%	15,224 $772,000
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $12,359 - $13,667	-277 Reduced 1.77%	15,374 $697,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $8,874 - $11,507	-182 Reduced 1.15%	15,651 $814,000
Q2 2018 Jul 27, 2018	SELL	$50.53 - $62.98 $12,632 - $15,745	-250 Reduced 1.55%	15,833 $876,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $4,494 - $5,173	-75 Reduced 0.46%	16,083 $1.02 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $9,050 - $9,867	-151 Reduced 0.93%	16,158 $990,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $900,746 - $1.04 Million	16,309	16,309 $1.04 Million

Others Institutions Holding BMY

# of Institutions

2,499

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $90.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandfield & Dodd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandfield & Dodd, LLC with notifications on news.

Account

Grandfield & Dodd, LLC Bristol Myers Squibb CO Transaction History